We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IJJ icon
526
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$2.62M 0.01%
21,232
-90
-0.4% -$10.7K
ROK icon
527
Rockwell Automation
ROK
$51.1B
$2.6M 0.01%
9,677
+416
+4% +$110K
EPAM icon
528
EPAM Systems
EPAM
$5.58B
$2.59M 0.01%
13,036
+3,112
+31% +$624K
CDNS icon
529
Cadence Design Systems
CDNS
$91.8B
$2.54M 0.01%
9,354
-630
-6% -$174K
ACGL icon
530
Arch Capital
ACGL
$36.5B
$2.5M 0.01%
22,382
-3,598
-14% -$374K
XYL icon
531
Xylem
XYL
$28.5B
$2.48M 0.01%
18,399
+605
+3% +$80.9K
ATO icon
532
Atmos Energy
ATO
$29.7B
$2.46M 0.01%
17,729
-2,936
-14% -$377K
NRG icon
533
NRG Energy
NRG
$26.2B
$2.4M 0.01%
26,374
-11,287
-30% -$898K
LBRDK icon
534
Liberty Broadband Class C
LBRDK
$4.89B
$2.4M 0.01%
30,989
+5,386
+21% +$333K
CQP icon
535
Cheniere Energy
CQP
$30.5B
$2.39M 0.01%
48,993
– –
LNG icon
536
Cheniere Energy
LNG
$54.2B
$2.38M 0.01%
13,241
-190
-1% -$34.2K
VONG icon
537
Vanguard Russell 1000 Growth ETF
VONG
$41.2B
$2.38M 0.01%
24,615
+1,755
+8% +$164K
EMXC icon
538
iShares MSCI Emerging Markets ex China ETF
EMXC
$22.1B
$2.37M 0.01%
38,833
+6,286
+19% +$377K
EMN icon
539
Eastman Chemical
EMN
$7.69B
$2.37M 0.01%
21,193
+1,042
+5% +$104K
STE icon
540
Steris
STE
$22.9B
$2.3M 0.01%
9,467
-115
-1% -$26.9K
FNDF icon
541
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$2.29M 0.01%
61,400
– –
MET icon
542
MetLife
MET
$62.4B
$2.28M 0.01%
27,626
+809
+3% +$60.4K
ALTR
543
DELISTED
Altair Engineering Inc
ALTR
$2.23M 0.01%
23,343
+2,334
+11% +$212K
LRN icon
544
Stride
LRN
$4.16B
$2.22M 0.01%
25,990
+910
+4% +$70.3K
AJG icon
545
Arthur J. Gallagher & Co
AJG
$69.1B
$2.2M 0.01%
7,835
-135
-2% -$38.1K
SE icon
546
Sea Limited
SE
$66.4B
$2.2M 0.01%
23,319
+19,940
+590% +$1.5M
PRU icon
547
Prudential Financial
PRU
$42.6B
$2.18M 0.01%
17,968
+1,234
+7% +$146K
SSD icon
548
Simpson Manufacturing
SSD
$7.79B
$2.15M 0.01%
11,239
+1,208
+12% +$217K
TPR icon
549
Tapestry
TPR
$30.3B
$2.15M 0.01%
45,674
+16,353
+56% +$675K
ENB icon
550
Enbridge
ENB
$120B
$2.13M 0.01%
52,542
-1,623
-3% -$62.5K
20 21
22
23 24

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.